drugset / Trial / NCT00027924

Combination Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Chronic Myelogenous Leukemia or Myelodysplastic Syndrome

NCT00027924 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Peripheral stem cell transplantation may be able to replace immune cells that were destroyed by chemotherapy used to kill tumor cells. Sometimes the transplanted cells are rejected by the body's normal tissues. Drugs such as cyclosporine may prevent this from happening. PURPOSE: Phase II trial to study the effectiveness of combination chemotherapy followed by peripheral stem cell transplantation in treating patients who have chronic myelogenous leukemia or myelodysplastic syndrome.

Timeline

Start
2001-10
Primary completion
2003-05
Completion
2003-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Busulfan Small molecule — Oral
Subject Fludarabine Small molecule — Intravenous
Background Cyclosporine Peptide — Oral
Background Methotrexate Small molecule — Intravenous